← Eichor
Study identifier: NCT04947280 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer

Condition: Bone Metastases · Breast Cancer  ·  Sponsor: Fudan University

PhasePhase 1/Phase 2
Planned participants120
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Fractionated stereotatic radiation therapy (FSRT) that very precisely delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. The purpose of this study is to find out if FSRT is safe and effective in the treatment of metastatic spinal tumors of breast cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Zhaozhi Yang, MD, Ph.D  ·  8618017317126  ·  yzzhi2006@yahoo.com.cn

Wei Shi, MD, Ph.D  ·  8618121299680  ·  wei.shi118@foxmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Fudan University Shanghai Cancer CenterShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04947280